Sarah Nam, VP of AI Strategy and Partnerships at AbbVie, and Anthropic’s Ivy Weng discuss how AbbVie is transforming pharmaceutical research and development with AI.
Sarah shares how AbbVie uses Claude for Life Sciences to reimagine drug discovery, from analyzing multimodal biological data to optimizing clinical trials with smarter patient stratification and adaptive protocols.
They also explore AbbVie’s approach to bringing AI skills to employees across the entire company.
Learn more about what Claude can do for life sciences: https://claude.com/solutions/life-sciences
